Skip to content
RxMonitor home

Medication

Gentamicin(e)

DIN 02082136 · Baxter Corporation Likely a generic

What it is

Active ingredients
Form and route
Solution · Intravenous
Schedule
PRESCRIPTION
Authorised since
1995-12-31

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

Products with the same active ingredient

No other medication authorised in Canada shares this active ingredient.

Health Canada groups products by their active ingredients. No other marketed product shares this one’s group, which usually means it is still the only authorised version — not that alternatives were hidden or missed.

Watch this medication

Ontario Drug Benefit coverage

As of 31 July 2026

This medication is not listed on the Ontario Drug Benefit formulary.

Not on the formulary is not the same as not covered. Private and workplace insurance, federal programs such as Non-Insured Health Benefits and Veterans Affairs, and every other province’s public plan are all outside what this page shows — Ontario is the only province RxMonitor holds coverage data for. Ontario may also fund a product that is not on the formulary through the Exceptional Access Program.

Check this medication on Ontario’s own coverage search →

Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.

How it is classified

Anatomical main group
Anti-infectives for systemic use
ATC code
J01GB03

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of J01GB03, see the WHO ATC/DDD Index.

Recalls and safety alerts

As of 12 August 2026
Recall:

Health Canada has published 2 recalls or safety alerts naming this product. Read them on Health Canada’s own site, and speak to a pharmacist before changing anything about how you take this medication.

  • GENTAMICIN(E) SULFATE: Solution bags may be leaking in affected lots.

    3 October 2023Product qualityType I

    Health Canada says: Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.

    Matched on the product name at the start of the notice.

  • Gentamicin(E) Sulfate: Solution bags may be leaking in affected lots.

    20 July 2023PackagingType I

    Health Canada says: Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.

    Matched on the product name at the start of the notice.

This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Gentamicin(e) How RxMonitor matches recalls, and how often it fails

Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.

Important:

Information only — this is not medical advice. RxMonitor shows what Health Canada and provincial drug programs have published about authorised products. It does not tell you what to take, whether a medication is right for you, or what dose to use.

Always talk to a pharmacist or physician about your own medication, and never start, stop or change one based on what you read here.